1. Low-Dose Peginterferon Alfa-2a Is Safe and Produces a Sustained Virologic Response in Patients With Chronic Hepatitis C and End-Stage Renal Disease 
Markus Peck–Radosavljevic, John Boletis, Fatih Besisik, Maria Lúcia Ferraz, Laurent Alric, Didier Samuel, Diethelm Messinger, Andreas Tietz, Hugo Cheinquer 
Clinical Gastroenterology and Hepatology 
Volume 9, Issue 3, Pages (March 2011)
DOI: /j.cgh
Copyright © 2011 AGA Institute Terms and Conditions

2. Figure 1 Patient flow diagram.
Clinical Gastroenterology and Hepatology 2011 9, DOI: ( /j.cgh )
Copyright © 2011 AGA Institute Terms and Conditions

3. Figure 2
Predictive value of undetectable HCV RNA(<50 IU/mL) at week 12 for SVR in the 135 μg/wk group(top) and in the 90 μg/wk group(bottom). Patients with missing HCV RNA results at week 12 are excluded from the analysis.
Clinical Gastroenterology and Hepatology 2011 9, DOI: ( /j.cgh )
Copyright © 2011 AGA Institute Terms and Conditions